Capricor Therapeutics
CAPR
CAPR
33 hedge funds and large institutions have $4.32M invested in Capricor Therapeutics in 2020 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 9 increasing their positions, 2 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0.99% more ownership
Funds ownership: 5.61% → 6.6% (+0.99%)
9% less call options, than puts
Call options by funds: $249K | Put options by funds: $274K
Holders
33
Holding in Top 10
–
Calls
$249K
Puts
$274K
Top Buyers
| 1 | +$647K | |
| 2 | +$518K | |
| 3 | +$415K | |
| 4 |
Two Sigma Investments
New York
|
+$189K |
| 5 |
Goldman Sachs
New York
|
+$169K |
Top Sellers
| 1 | -$322K | |
| 2 | -$13K | |
| 3 | -$2K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$1.91K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$1.03K |